Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disorder
Clinical trial NCT00088036 · COMPLETED
Trial details
- NCT number
- NCT00088036
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-02-01
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.